Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Verschiedene

From trial to clinic: psilocybin’s efficacy in routine treatment-resistant depression

From trial to clinic: psilocybin’s efficacy in routine treatment-resistant depression

Vassilis Martiadis

The Lancet regional Health Europe, Volume 67, 101780, August 2026

https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(26)00192-4/fulltexthttps://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(26)00192-4/fulltext